Clinical Trial Update: Irinotecan and Capecitabine in Treating Women With Advanced Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the combination of irinotecan and capecitabine in women with advanced breast cancer has completed. The report covers safety and prelimi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Camptosar (irinotecan)
• Xeloda (capecitabine)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED